These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23706388)

  • 1. Frequency of toxicity with chemical conversion of atrial fibrillation with dofetilide.
    Brumberg G; Gera N; Pray C; Adelstein E; Barrington W; Bazaz R; Mendenhall GS; Nemec J; Voigt A; Wang NC; Schwartzman D; Saba S; Jain SK
    Am J Cardiol; 2013 Aug; 112(4):505-8. PubMed ID: 23706388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation.
    Naksuk N; Sugrue AM; Padmanabhan D; Kella D; DeSimone CV; Kapa S; Asirvatham SJ; Lee HC; Ackerman MJ; Noseworthy PA
    J Interv Card Electrophysiol; 2019 Mar; 54(2):189-196. PubMed ID: 30353374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dofetilide-induced long QT and torsades de pointes.
    Aktas MK; Shah AH; Akiyama T
    Ann Noninvasive Electrocardiol; 2007 Jul; 12(3):197-202. PubMed ID: 17617063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dofetilide induced torsade de pointes: mechanism, risk factors and management strategies.
    Jaiswal A; Goldbarg S
    Indian Heart J; 2014; 66(6):640-8. PubMed ID: 25634399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnitude of increase in QTc interval after initiation of dofetilide in patients with persistent atrial fibrillation is associated with increased rates of pharmacological cardioversion and long-term freedom from recurrent atrial fibrillation.
    Huang HD; Waks JW; Steinhaus DA; Zimetbaum P
    Heart Rhythm; 2016 Jul; 13(7):1410-7. PubMed ID: 26921760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked QT prolongation and torsades de pointes secondary to acute ischemia in an elderly man taking dofetilide for atrial fibrillation: a cautionary tale.
    Nagra BS; Ledley GS; Kantharia BK
    J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):191-5. PubMed ID: 16211208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic Conversion during Dofetilide Treatment for Persistent Atrial Fibrillation.
    Steinberg JS; Shah Y; Szepietowska B
    Pacing Clin Electrophysiol; 2017 Jun; 40(6):667-671. PubMed ID: 28220940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase IV trial evaluating the effectiveness and safety of dofetilide.
    Guanzon AV; Crouch MA
    Ann Pharmacother; 2004; 38(7-8):1142-7. PubMed ID: 15161945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical proarrhythmia with dofetilide: monomorphic VT and exercise-induced torsade de pointes.
    Reiffel JA
    Pacing Clin Electrophysiol; 2005 Aug; 28(8):877-9. PubMed ID: 16105020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Sotalol and Dofetilide Dosing at a Large Academic Medical Center.
    Ting C; Malloy R; Knowles D
    J Cardiovasc Pharmacol Ther; 2020 Sep; 25(5):438-443. PubMed ID: 32347108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
    Torp-Pedersen C; Møller M; Bloch-Thomsen PE; Køber L; Sandøe E; Egstrup K; Agner E; Carlsen J; Videbaek J; Marchant B; Camm AJ
    N Engl J Med; 1999 Sep; 341(12):857-65. PubMed ID: 10486417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of dofetilide in adult patients with atrial arrhythmias and congenital heart disease: A PACES collaborative study.
    El-Assaad I; Al-Kindi SG; Abraham J; Sanatani S; Bradley DJ; Halsey C; Law IH; Balaji S; Shetty I; Aziz PF
    Heart Rhythm; 2016 Oct; 13(10):2034-9. PubMed ID: 27435587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dofetilide dose reductions and discontinuations in women compared with men.
    Pokorney SD; Yen DC; Campbell KB; Allen LaPointe NM; Sheng S; Thomas L; Bahnson TD; Daubert JP; Picini JP; Jackson KP; Thomas KL; Al-Khatib SM
    Heart Rhythm; 2018 Apr; 15(4):478-484. PubMed ID: 29605013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter.
    Banchs JE; Wolbrette DL; Samii SM; Penny-Peterson ED; Patel PP; Young SK; Gonzalez MD; Naccarelli GV
    J Interv Card Electrophysiol; 2008 Nov; 23(2):111-5. PubMed ID: 18688699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
    McClellan KJ; Markham A
    Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute conversion of persistent atrial fibrillation during dofetilide loading does not predict long-term atrial fibrillation-free survival.
    Khurshid S; Akerman S; Man JP; Supple G; Dixit S; Epstein AE; Marchlinski FE; Frankel DS
    J Interv Card Electrophysiol; 2015 Mar; 42(2):117-24. PubMed ID: 25620152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exaggerated QT prolongation after cardioversion of atrial fibrillation.
    Choy AM; Darbar D; Dell'Orto S; Roden DM
    J Am Coll Cardiol; 1999 Aug; 34(2):396-401. PubMed ID: 10440151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk prediction for adverse events during initiation of sotalol and dofetilide for the treatment of atrial fibrillation.
    Agusala K; Oesterle A; Kulkarni C; Caprio T; Subacius H; Passman R
    Pacing Clin Electrophysiol; 2015 Apr; 38(4):490-8. PubMed ID: 25626340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of Oral Dofetilide Reloading for Treatment of Atrial Arrhythmias.
    Cho JH; Youn SJ; Moore JC; Kyriakakis R; Vekstein C; Militello M; Poe SM; Wolski K; Tchou PJ; Varma N; Niebauer MJ; Bhargava M; Saliba WI; Wazni OM; Lindsay BD; Wilkoff BL; Chung MK
    Circ Arrhythm Electrophysiol; 2017 Oct; 10(10):. PubMed ID: 29038104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.
    Liu G; Xue X; Gao C; Huang J; Qi D; Zhang Y; Dong JZ; Ma CS; Yan GX
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28522677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.